May 10, 2017
Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study
Media
May 08, 2017
Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017
May 08, 2017
Nexstim Plc Terminates Market Making Agreement with Pareto Securities AB in Nasdaq First North Sweden
May 04, 2017
Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases
May 04, 2017
Altimmune Completes Merger with PharmAthene Creating Immunotherapeutics Company Targeting Infectious Diseases
May 03, 2017
GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer
May 02, 2017
Q1 2017 General Market Overview
April 28, 2017
Updated results from Phase 1/2 trial of Betalutin® in NHL accepted for presentation at the International Conference on Malignant Lymphoma in June
April 27, 2017
Nordic Nanovector to Present at Upcoming Deutsche Bank and Jefferies Healthcare Conferences
April 27, 2017
GenSight Biologics to Present GS010 at the 4th Annual Retinal Cell & Gene Therapy Innovation Summit